Study of Lanreotide Autogel 120 mg in Patients With Non-functioning Entero- Pancreatic Endocrine Tumour

Clinical trial NCT00842348 · COMPLETED

Trial details

NCT number: NCT00842348
Sponsor: Ipsen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Non Functioning Entero-pancreatic Endocrine Tumour

Start date: 2009-02-01
Primary completion: 2015-12-01
Enrollment: 89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.